Screener
Amphastar Pharmaceuticals AMPH Return on equity
Discontinued — last reported Q4 '21
Return on equity at other companies
Other financials
Where this comes from
Calculated from Amphastar Pharmaceuticals’s reported figures.
Based on trailing twelve months.
The source filing: Amphastar Pharmaceuticals’s 10-K, filed March 1, 2023. Open the filing →
- Filed
- Mar 1, 2023
- Fiscal year
- FY2022
- Accession
- 0001297184-23-000019
FAQ
- What is Amphastar Pharmaceuticals's return on equity?
- Amphastar Pharmaceuticals (AMPH) reported return on equity of 14.7% in Q4 2021.
- What does return on equity mean?
- Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.
Ask your AI about Amphastar Pharmaceuticals's return on equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude